Document is current
Any future updates will be listed below
-
Authors
Shinkai, Masayuki
Imano, Motohiro
Yokokawa, Masaki
Tanaka, Ryo
Matsuyama, Jin
Shimokawa, Toshio
Kawakami, Hisato
Satoh, Taroh
Yasuda, Takushi
Furukawa, Hiroshi
- License Information
-
More Information
Article History
First Online: 11 February 2025
Disclosures
: Hisato Kawakami: honoraria from Taiho Pharmaceutical Co. Ltd.; consulting or advisory fees from Astellas Pharma Inc. and Daiichi-Sankyo Co. Ltd.; honoraria from Bristol-Myers Squibb Co. Ltd., Ono Pharmaceutical Co. Ltd., Eli Lilly Japan K.K., MSD K.K., Chugai Pharmaceutical Co. Ltd., Daiichi-Sankyo Co. Ltd., Merck Biopharma Co. Ltd., Takeda Pharmaceutical Co. Ltd., Yakult Pharmaceutical Industry (Takata Pharmaceutical Co. Ltd), Otsuka Pharmaceutical Co. Ltd., Novartis International AG, Bayer Yakuhin, Ltd, and Nippon Kayaku Co. Ltd.; and research funding from Bristol-Myers Squibb Co. Ltd., Taiho Pharmaceutical Co. Ltd., Kobayashi Pharmaceutical Co. Ltd., and Eisai Co. Ltd.Taroh Satoh: honoraria from Daiichi Sankyo Co. Ltd., Ono Pharmaceutical Co. Ltd., Bristol-Myers Squibb Co. Ltd., Lilly Japan K.K., Taiho Pharmaceutical Co. Ltd., and Yakult.Pharmaceutical Industry; research funding from Daiichi Sankyo Co. Ltd., Ono Pharmaceutical Co. Ltd., Bristol-Myers Squibb Co. Ltd., Lilly Japan K.K., Taiho Pharmaceutical Co. Ltd., and Yakult Pharmaceutical Industry.; scholarship donations from Taiho Pharmaceutical Co. Ltd.; and endowed chairs from Ono Pharmaceutical Co. Ltd., Yakult Pharmaceutical Industry, and Chugai Pharmaceutical Co.
